ONdrugDelivery – Opportunities for Innovation with Biosimilars
As biologic formulation technologies and regulatory parameters rapidly evolve, which issues and opportunities should remain highest on your radar? With market activity posting double-digit growth, the biosimilars industry has now reached a critical inflection point. The healthcare sector is increasingly exploring patient self-administration options for the treatment of numerous conditions. Forward-thinking organizations — well aware of rising adoption — are beginning to boost R&D, consider new commercial innovations and reassess portfolio management strategies. Read our February 2023 ONdrugDelivery article for expert biosimilars insights from Iain Simpson, PhD, commercial director at Phillips-Medisize, and George Spooner, chief of staff at Oxford Medical Products.
